Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Company    BMY

BRISTOL-MYERS SQUIBB COMPANY

(BMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BRISTOL-MYERS SQUIBB COMPA
07/06BRISTOL MYERS SQUIBB : Dragonfly Therapeutics Expands Collaboration With Bristol..
DJ
07/02BRISTOL-MYERS SQUIBB COMPANY : Ex-dividend day for
FA
06/29BRISTOL MYERS SQUIBB : European Commission Approves Reblozyl for the Treatment o..
AQ
06/26BRISTOL MYERS SQUIBB : Immunology & Cardiovascular Presentation
PU
06/26BRISTOL MYERS SQUIBB : Myers, Acceleron Get EU Approval for Reblozyl
DJ
06/26BRISTOL MYERS SQUIBB : European Commission Approves Reblozyl (luspatercept) for ..
BU
06/25BRISTOL MYERS SQUIBB : Investor Series Presentation
PU
06/22BRISTOL MYERS SQUIBB : Early Pipeline & Immuno-Oncology Presentation
PU
06/22BRISTOL MYERS SQUIBB : Supplemental epidemiology information
PU
06/18VIDENCE, LLC : Launched to Set Standard for High-Quality Cancer Data, Research a..
PR
06/18BRISTOL MYERS SQUIBB : to Announce Results for Second Quarter 2020 on August 6, ..
BU
06/16BRISTOL MYERS SQUIBB : Announces Commencement of Registered Exchange Offers
BU
06/12BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo (nivolu..
AQ
06/11BRISTOL MYERS SQUIBB : Announces Dividend
BU
06/11BRISTOL-MYERS SQUIBB COMPANY : Dividends
CO
More most relevant news
All news about BRISTOL-MYERS SQUIBB COMPA
07/06BRISTOL MYERS SQUIBB : Dragonfly Therapeutics Expands Collaboration With Bristol..
DJ
07/02BRISTOL-MYERS SQUIBB COMPANY : Ex-dividend day for
FA
06/29BRISTOL MYERS SQUIBB : European Commission Approves Reblozyl for the Treatment o..
AQ
06/29SELLAS Life Sciences Advancing Its Innovative Immunotherapy Across Phase 1, 2..
AQ
06/26BRISTOL MYERS SQUIBB : Immunology & Cardiovascular Presentation
PU
06/26BRISTOL MYERS SQUIBB : Myers, Acceleron Get EU Approval for Reblozyl
DJ
06/26BRISTOL MYERS SQUIBB : European Commission Approves Reblozyl (luspatercept) for ..
BU
06/26MERCK : Intensity Therapeutics Announces Publication of Research Reporting that ..
AQ
06/25BRISTOL MYERS SQUIBB : Investor Series Presentation
PU
06/22BRISTOL MYERS SQUIBB : Early Pipeline & Immuno-Oncology Presentation
PU
More news
News in other languages on BRISTOL-MYERS SQUIBB COMPA
07/06BRISTOL MYERS SQUIBB : Dragonfly Therapeutics Expands Collaboration With Bristol..
07/02BRISTOL-MYERS SQUIBB COMPANY : Ex-dividend day for
06/29BRISTOL MYERS SQUIBB : European Commission Approves Reblozyl for the Treatment o..
06/29SELLAS Life Sciences Advancing Its Innovative Immunotherapy Across Phase 1, 2..
06/26BRISTOL MYERS SQUIBB : Immunology & Cardiovascular Presentation
06/26BRISTOL MYERS SQUIBB : Myers, Acceleron Get EU Approval for Reblozyl
06/26BRISTOL MYERS SQUIBB : European Commission Approves Reblozyl (luspatercept) for ..
06/26MERCK : Intensity Therapeutics Announces Publication of Research Reporting that ..
06/25BRISTOL MYERS SQUIBB : Investor Series Presentation
06/22BRISTOL MYERS SQUIBB : Early Pipeline & Immuno-Oncology Presentation
Press releases
06/29BRISTOL MYERS SQUIBB : European Commission Approves Reblozyl for the Treatment o..
AQ
06/29SELLAS Life Sciences Advancing Its Innovative Immunotherapy Across Phase 1, 2..
AQ
06/26BRISTOL MYERS SQUIBB : Immunology & Cardiovascular Presentation
PU
06/26BRISTOL MYERS SQUIBB : European Commission Approves Reblozyl (luspatercept) for ..
BU
06/26MERCK : Intensity Therapeutics Announces Publication of Research Reporting that ..
AQ
More press releases
Upcoming event on BRISTOL-MYERS SQUIBB COMPA